Published in Circ J on April 01, 2006
Intra-myocardial biomaterial injection therapy in the treatment of heart failure: Materials, outcomes and challenges. Acta Biomater (2010) 1.33
Delivery of basic fibroblast growth factor with a pH-responsive, injectable hydrogel to improve angiogenesis in infarcted myocardium. Biomaterials (2010) 1.15
Extended and sequential delivery of protein from injectable thermoresponsive hydrogels. J Biomed Mater Res A (2012) 0.89
Intramyocardial injection of a synthetic hydrogel with delivery of bFGF and IGF1 in a rat model of ischemic cardiomyopathy. Biomacromolecules (2014) 0.86
Improved myocardial perfusion and cardiac function by controlled-release basic fibroblast growth factor using fibrin glue in a canine infarct model. J Zhejiang Univ Sci B (2010) 0.84
Angiogenic therapy for cardiac repair based on protein delivery systems. Heart Fail Rev (2012) 0.83
Effect of bone marrow-derived extracellular matrix on cardiac function after ischemic injury. Biomaterials (2012) 0.82
Bone marrow-derived multipotent stromal cells promote myocardial fibrosis and reverse remodeling of the left ventricle. Stem Cells Int (2015) 0.77
In vivo experience with natural scaffolds for myocardial infarction: the times they are a-changin'. Stem Cell Res Ther (2015) 0.76
Rad18 guides poleta to replication stalling sites through physical interaction and PCNA monoubiquitination. EMBO J (2004) 4.42
Surgical treatment of congenital coronary artery fistulas: 27 years' experience and a review of the literature. J Card Surg (2002) 1.96
Tumor suppressor WARTS ensures genomic integrity by regulating both mitotic progression and G1 tetraploidy checkpoint function. Oncogene (2004) 1.86
Aliskiren enhances protective effects of valsartan against type 2 diabetic nephropathy in mice. J Hypertens (2010) 1.52
The width of a gastric tube has no impact on outcome after esophagectomy. Am J Surg (2004) 1.49
Off-pump coronary bypass grafting is safe and efficient in patients with left main disease and higher EuroScore. Eur J Cardiothorac Surg (2009) 1.49
Local sustained release of prostaglandin E1 induces neovascularization in murine hindlimb ischemia. Circ J (2009) 1.43
Inhibition of DNA binding of Sox2 by the SUMO conjugation. Biochem Biophys Res Commun (2006) 1.38
Nifedipine increases energy expenditure by increasing PGC-1α expression in skeletal muscle. Hypertens Res (2011) 1.38
Macrophage-derived angiopoietin-like protein 2 accelerates development of abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol (2012) 1.22
Methylated DNA-binding domain 1 and methylpurine-DNA glycosylase link transcriptional repression and DNA repair in chromatin. Proc Natl Acad Sci U S A (2003) 1.21
Defining the roles of beta-catenin and plakoglobin in cell-cell adhesion: isolation of beta-catenin/plakoglobin-deficient F9 cells. Cell Struct Funct (2005) 1.13
Pravastatin enhances beneficial effects of olmesartan on vascular injury of salt-sensitive hypertensive rats, via pleiotropic effects. Arterioscler Thromb Vasc Biol (2006) 1.08
Overlapping roles of the methylated DNA-binding protein MBD1 and polycomb group proteins in transcriptional repression of HOXA genes and heterochromatin foci formation. J Biol Chem (2007) 1.04
Id1 gene transfer confers angiogenic property on fully differentiated endothelial cells and contributes to therapeutic angiogenesis. Circulation (2005) 0.98
Perivascular adipose tissue-secreted angiopoietin-like protein 2 (Angptl2) accelerates neointimal hyperplasia after endovascular injury. J Mol Cell Cardiol (2013) 0.96
Protein kinase A-regulated nucleocytoplasmic shuttling of Id1 during angiogenesis. J Biol Chem (2007) 0.95
Cardiac displacement with a congenital complete left-sided pericardial defect in a patient with exertional angina pectoris--a case report. Angiology (2004) 0.94
Therapeutic treatment with sustained-release platelet-rich plasma restores blood perfusion by augmenting ischemia-induced angiogenesis and arteriogenesis in diabetic mice. J Vasc Res (2010) 0.91
Intravascular papillary endothelial hyperplasia in an aneurysm of the superficial temporal artery: Report of a case. Surg Today (2011) 0.88
Enhancement of cardiac oxidative stress by tachycardia and its critical role in cardiac hypertrophy and fibrosis. J Hypertens (2006) 0.87
Outcome of histologically node-negative esophageal squamous cell carcinoma. World J Surg (2002) 0.84
New therapeutic approach for impaired arteriogenesis in diabetic mouse hindlimb ischemia. Circ J (2008) 0.83
Successful therapy of brachiocephalic arteriogastric fistula after esophagectomy. Ann Thorac Surg (2011) 0.82
Predictive factors for platelet number after cardiopulmonary bypass and postoperative blood loss. ASAIO J (2002) 0.82
Quality of life after esophagectomy for cancer: an assessment using the questionnaire with the face scale. Surg Today (2002) 0.82
Combined treatment of sustained-release basic fibroblast growth factor and sarpogrelate enhances collateral blood flow effectively in rabbit hindlimb ischemia. Circ J (2006) 0.79
Changes in respiratory condition after thymectomy for patients with myasthenia gravis. Ann Thorac Cardiovasc Surg (2003) 0.79
Electrocardiographic gated (99m)Tc-MIBI SPECT for functional assessment of patients after coronary artery bypass surgery: comparison of wall thickening and wall motion analysis. J Nucl Med (2002) 0.79
Different roles of Foxo1 and Foxo3 in the control of endothelial cell morphology. Genes Cells (2009) 0.79
The value of angiogenic therapy with intramyocardial administration of basic fibroblast growth factor to treat severe coronary artery disease. Ann Thorac Cardiovasc Surg (2010) 0.78
Coculture of Th cells with interleukin (IL)-7 in the absence of antigenic stimuli induced T-cell anergy reversed by IL-15. Hum Immunol (2005) 0.78
Monocyte chemotactic S19 ribosomal protein dimer in atherosclerotic vascular lesion. Virchows Arch (2005) 0.78
Three-field dissection or two-field dissection?--A proposal of new algorithm for lymphadenectomy. Hepatogastroenterology (2004) 0.78
Sustained release of prostaglandin E1 potentiates the impaired therapeutic angiogenesis by basic fibroblast growth factor in diabetic murine hindlimb ischemia. Circ J (2008) 0.76
A simple method of intraoperative preparation of a stent graft for distal aortic arch aneurysm. J Thorac Cardiovasc Surg (2003) 0.75
Onset of liver metastasis after histologically curative resection of pancreatic cancer. Surg Today (2006) 0.75
Combined treatment with sustained-release basic fibroblast growth factor and heparin enhances neovascularization in hypercholesterolemic mouse hindlimb ischemia. Circ J (2007) 0.75
Giant yolk sac tumor operated under percutaneous cardiopulmonary support (PCPS) and aspiration device. Ann Thorac Cardiovasc Surg (2008) 0.75
[Surgical treatment for infective prosthetic mitral valve endocarditis with cardiogenic shock; report of a case]. Kyobu Geka (2014) 0.75
[Graft Pseudoaneurysm after Ascending to Abdominal Aorta Bypass for Atypical Coarctation Due to Aortitis Syndrome;Report of a Case]. Kyobu Geka (2017) 0.75
Therapeutic angiogenesis for ischemic heart disease. Ann Thorac Cardiovasc Surg (2002) 0.75
Therapeutic angiogenesis with autologous hepatic tissue implantation and omental wrapping. Circ J (2008) 0.75
Novel approach with intratracheal administration of microgelatin hydrogel microspheres incorporating basic fibroblast growth factor for rescue of rats with monocrotaline-induced pulmonary hypertension. J Thorac Cardiovasc Surg (2008) 0.75
[Total arch replacement for ruptured Stanford type B aortic dissection with thrombosed pseudolumen presenting hemodynamic deterioration]. Kyobu Geka (2014) 0.75
A potential of autologous pericardium for a sustained-release carrier of vancomycin: a pilot study in vitro. J Thorac Cardiovasc Surg (2008) 0.75
Cell transplantation for cardiac repair. Ann Thorac Cardiovasc Surg (2006) 0.75
Protective effect of melatonin on human peripheral blood hematopoeitic stem cells against doxorubicin cytotoxicity. Anticancer Res (2005) 0.75
[Second use of preserved aortic cusps for bentall procedure after aortic valve replacement with intravalvular implantation technique in aortitis syndrome]. Kyobu Geka (2014) 0.75
[Redo Aortic and Mitral Valve Replacement by Manouguian's Procedure for Active Prosthetic Valve Infection]. Kyobu Geka (2016) 0.75
Favorable Clinical Outcomes of Transcatheter Aortic Valve Implantation in Japanese Patients - First Report From the Post-Approval K-TAVI Registry. Circ J (2016) 0.75
Left atrial mass following total arch replacement. J Card Surg (2010) 0.75
Early results and problems with St. Jude Medical Symmetry bypass system in Japan. Asian Cardiovasc Thorac Ann (2004) 0.75
Prognostic factors of curatively resected esophageal carcinoma associated with multiple metastatic lymph nodes. Hepatogastroenterology (2006) 0.75
[Left ventricular rupture following mitral valve replacement]. Kyobu Geka (2004) 0.75
Use of the Konno procedure in an 80-year-old woman with aortic stenosis, a narrow left ventricular outflow tract, and a small aortic annulus. Ann Thorac Cardiovasc Surg (2013) 0.75
Impact of polyvascular disease on clinical outcomes in patients undergoing coronary revascularization: an observation from the CREDO-Kyoto Registry Cohort-2. Atherosclerosis (2013) 0.75
[Valve replacement for tricuspid infective endocarditis presenting paradoxical cerebral embolism]. Kyobu Geka (2014) 0.75
Coronary artery bypass grafting using a bifurcating radial artery. Interact Cardiovasc Thorac Surg (2003) 0.75